Quantitative analysis of the side-branch orifice after bifurcation stenting using en-face processing of OCT images: a comparison between Xience V and Resolute Integrity stents

Coron Artery Dis. 2016 Jan;27(1):19-28. doi: 10.1097/MCA.0000000000000319.

Abstract

Objective: Methods for intravascular assessment of the side-branch (SB) orifice after stenting are not readily available. The aim of this study was to assess the utility of an en-face projection processing for optical coherence tomography (OCT) images for SB evaluation.

Methods: Measurements of the SB orifice obtained using en-face OCT images were validated using a phantom model. Linear regression modeling was applied to estimated area measurements made on the en-face images. The SB orifice was then analyzed in 88 patients with bifurcation lesions treated with either Xience V (everolimus-eluting stent) or Resolute Integrity [zotarolimus-eluting stent (ZES)]. The SB orifice area (A) and the area obstructed by struts (B) were calculated, and the %open area was evaluated as (A-B)/A*100.

Results: Linear regression modeling demonstrated that the observed departures of the intercept and slope were not significantly different from 0 (-0.12 ± 0.22, P=0.59) and 1 (1.01 ± 0.06, R(2)=0.88, P=0.87), respectively. In cases without SB dilatation, the %open area was significantly larger in the everolimus-eluting stent group (n=25) than in the ZES group [n=32; 89.2% (83.7-91.3) vs. 84.3% (78.9-87.8), P=0.04]. A significant difference in %open area between cases with and those without SB dilatation was demonstrated in the ZES group [91.4% (86.1-94.0) vs. 84.3% (78.9-87.8), P=0.04].

Conclusion: The accuracy of SB orifice measurement on an en-face OCT image was validated using a phantom model. This novel approach enables quantitative evaluation of the differences in SB orifice area free from struts among different stent types and different treatment strategies in vivo.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials
  • Coronary Angiography
  • Coronary Stenosis / diagnosis
  • Coronary Stenosis / surgery*
  • Coronary Vessels / pathology*
  • Coronary Vessels / surgery
  • Drug-Eluting Stents*
  • Everolimus / pharmacology*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Membranes, Artificial
  • Middle Aged
  • Phantoms, Imaging
  • Polyglactin 910*
  • Prosthesis Design
  • Reproducibility of Results
  • Sirolimus / analogs & derivatives*
  • Sirolimus / pharmacology
  • Tomography, Optical Coherence / methods*

Substances

  • Biocompatible Materials
  • Membranes, Artificial
  • Resolut
  • Polyglactin 910
  • Everolimus
  • zotarolimus
  • Sirolimus